Loading...
Loading...
IRIX| Name | Value |
|---|---|
| Revenues | 13.7M |
| Cost of Revenue | 7.8M |
| Gross Profit | 5.9M |
| Operating Expense | 8.3M |
| Operating I/L | -2.3M |
| Other Income/Expense | 0.3M |
| Interest Income | 0.0M |
| Pretax | -2.1M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | -2.1M |
IRIDEX Corporation is an ophthalmic medical technology company that provides therapeutic laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. Its products include laser consoles for glaucoma, diabetic macular edema, and other retinal diseases, as well as delivery devices such as scanning laser systems and probes for various ophthalmic procedures. The company serves ophthalmologists, research and teaching hospitals, surgical centers, and office clinics, marketing its products through direct and independent sales force in the United States and international independent distributors.
